Robert Meyer Biography and Net Worth

Dr. Meyer has served as one of our directors since March 2018. He currently serves as Principal, Drug and Biological Products at Greenleaf Health, an FDA-focused strategic advising company. He is also an Associate Professor of Public Health Sciences at the University of Virginia, where he was formerly the Director of the Virginia Center for Translational and Regulatory Sciences from 2013-2017. He has also served on the board of Translate Bio, Lexington MA since 2019. Dr. Meyer previously was on the board of Correvio Pharma (nee Cardiome) and was a Trustee of the US Pharmacopeia for the 2015-2020 cycle.  Prior to joining the faculty at UVA, Dr. Meyer was Vice President and Head, Global Regulatory Strategy, Policy and Safety at Merck Research Laboratories (MRL), joining Merck in October 2007. Prior to Merck, Dr. Meyer worked for the U.S. Food and Drug Administration (FDA) from 1994-2007. In his last 5 years at the FDA, Dr. Meyer was the Director for the Office of Drug Evaluation II (ODEII) within Center for Drug Evaluation and Research (CDER), with responsibilities for pulmonary and allergy, metabolic and endocrine, and analgesics, anesthetics and rheumatologic drug products. Dr. Meyer holds a B.A. from Lehigh University and an M.D. from the University of Connecticut School of Medicine.